PBPK modeling supports approval of breakthrough cancer drug
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…
Certara2020年10月23日
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
Certara2020年10月20日
Best Practices for Small to Mid-Size Companies to Advance Drug Discovery Programs
研究の必要性によって規模を変更する能力を持つことが成功にとって極めて重要です。Understanding when the…
Certara2020年10月12日
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in…
Certara2020年10月12日
Stay on Track and Get Some Sleep: Marketing Application Best Practices
Without careful execution and the ability to navigate unexpected challenges, marketing application submissions are prone…
Certara2020年10月7日
